These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9044837)

  • 1. Induction of DNA topoisomerase II-mediated DNA cleavage by beta-lapachone and related naphthoquinones.
    Frydman B; Marton LJ; Sun JS; Neder K; Witiak DT; Liu AA; Wang HM; Mao Y; Wu HY; Sanders MM; Liu LF
    Cancer Res; 1997 Feb; 57(4):620-7. PubMed ID: 9044837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin.
    Li CJ; Averboukh L; Pardee AB
    J Biol Chem; 1993 Oct; 268(30):22463-8. PubMed ID: 8226754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of potentially lethal DNA damage repair in human tumor cells by beta-lapachone, an activator of topoisomerase I.
    Boothman DA; Trask DK; Pardee AB
    Cancer Res; 1989 Feb; 49(3):605-12. PubMed ID: 2535961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reaction of beta-lapachone and related naphthoquinones with 2-mercaptoethanol: a biomimetic model of topoisomerase II poisoning by quinones.
    Neder K; Marton LJ; Liu LF; Frydman B
    Cell Mol Biol (Noisy-le-grand); 1998 May; 44(3):465-74. PubMed ID: 9620443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mechanisms of DNA topoisomerase II inhibition by pyranonaphthoquinone derivatives-eleutherin, alpha lapachone, and beta lapachone.
    Krishnan P; Bastow KF
    Biochem Pharmacol; 2000 Nov; 60(9):1367-79. PubMed ID: 11008131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53-independent response.
    Planchon SM; Wuerzberger S; Frydman B; Witiak DT; Hutson P; Church DR; Wilding G; Boothman DA
    Cancer Res; 1995 Sep; 55(17):3706-11. PubMed ID: 7641180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mechanism of cellular DNA topoisomerase II inhibition by the pyranonaphthoquinone derivatives alpha-lapachone and beta-lapachone.
    Krishnan P; Bastow KF
    Cancer Chemother Pharmacol; 2001 Mar; 47(3):187-98. PubMed ID: 11320661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of resistance in a human cell line exposed to sequential topoisomerase poisoning.
    Saleem A; Ibrahim N; Patel M; Li XG; Gupta E; Mendoza J; Pantazis P; Rubin EH
    Cancer Res; 1997 Nov; 57(22):5100-6. PubMed ID: 9371509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,2-Naphthoquinone as a Poison of Human Type II Topoisomerases.
    Collins JA; Osheroff N
    Chem Res Toxicol; 2021 Apr; 34(4):1082-1090. PubMed ID: 33760604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced sensitivity to camptothecin of topoisomerase I from a L5178Y mouse lymphoma subline sensitive to X-radiation.
    Kowalska-Loth B; Staron K; Buraczewska I; Szumiel I; Kapiszewska M; Lange CS
    Biochim Biophys Acta; 1993 Feb; 1172(1-2):117-23. PubMed ID: 8382526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis in MCF-7:WS8 breast cancer cells by beta-lapachone.
    Wuerzberger SM; Pink JJ; Planchon SM; Byers KL; Bornmann WG; Boothman DA
    Cancer Res; 1998 May; 58(9):1876-85. PubMed ID: 9581828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topoisomerase-I inhibitors for human malignant glioma: differential modulation of p53, p21, bax and bcl-2 expression and of CD95-mediated apoptosis by camptothecin and beta-lapachone.
    Weller M; Winter S; Schmidt C; Esser P; Fontana A; Dichgans J; Groscurth P
    Int J Cancer; 1997 Nov; 73(5):707-14. PubMed ID: 9398050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The production of chromosomal alterations by beta-lapachone, an activator of topoisomerase I.
    Degrassi F; De Salvia R; Berghella L
    Mutat Res; 1993 Aug; 288(2):263-7. PubMed ID: 7688086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of topoisomerase modulators on cisplatin cytotoxicity in human ovarian carcinoma cells.
    Katz EJ; Vick JS; Kling KM; Andrews PA; Howell SB
    Eur J Cancer; 1990; 26(6):724-7. PubMed ID: 2168194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered topoisomerase I activity and recombination activating gene expression in a human leukemia cell line resistant to doxorubicin.
    Riou JF; Grondard L; Petitgenet O; Abitbol M; Lavelle F
    Biochem Pharmacol; 1993 Sep; 46(5):851-61. PubMed ID: 8396937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yeast cytotoxic sensitivity to the antitumour agent β-lapachone depends mainly on oxidative stress and is largely independent of microtubule- or topoisomerase-mediated DNA damage.
    Ramos-Pérez C; Lorenzo-Castrillejo I; Quevedo O; García-Luis J; Matos-Perdomo E; Medina-Coello C; Estévez-Braun A; Machín F
    Biochem Pharmacol; 2014 Nov; 92(2):206-19. PubMed ID: 25241291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The topoisomerase I inhibitors, camptothecin and beta-lapachone, induce apoptosis of human retinal pigment epithelial cells.
    Hueber A; Esser P; Heimann K; Kociok N; Winter S; Weller M
    Exp Eye Res; 1998 Nov; 67(5):525-30. PubMed ID: 9878214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of eukaryotic DNA topoisomerase I and II activities by indoloquinolinedione derivatives.
    Riou JF; Helissey P; Grondard L; Giorgi-Renault S
    Mol Pharmacol; 1991 Nov; 40(5):699-706. PubMed ID: 1658605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of hydrogen peroxide in topoisomerase inhibitor beta-lapachone-induced apoptosis and differentiation in human leukemia cells.
    Chau YP; Shiah SG; Don MJ; Kuo ML
    Free Radic Biol Med; 1998 Mar; 24(4):660-70. PubMed ID: 9559879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of doxorubicin and β-lapachone analogs as anticancer agents, a biological and computational study.
    Mercado-Sánchez I; López J; Chávez-Rocha R; Vargas-Rodríguez I; Bazán-Jiménez A; Segovia-Mendoza M; Prado-Garcia H; Vázquez MA; García-Becerra R; Garcia-Revilla MA
    Chem Biol Drug Des; 2024 Jul; 104(1):e14596. PubMed ID: 39054402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.